Short Interest in Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Drops By 20.5%

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the recipient of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 393,700 shares, a decrease of 20.5% from the February 13th total of 495,100 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 3,937.0 days.

Kyowa Kirin Stock Performance

KYKOF remained flat at $13.65 during midday trading on Tuesday. The company’s fifty day simple moving average is $14.09 and its two-hundred day simple moving average is $16.60. Kyowa Kirin has a 12-month low of $12.32 and a 12-month high of $22.21.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.